The presence of biomarkers, even in small amounts, can shape the course of treatment for a patient, says Andy Guinigundo, MSN, RN, CNP, ANP-BC.

which could confound evaluating for any associations between antiestrogen therapy and cognitive performance. While this study controlled for marital status, number of children, number of years of ...

Arvinas stock lost half its value Tuesday after the biotech company reported mixed results from its Pfizer-partnered breast cancer drug.

The estrogen receptor-positive (ER+) subtype accounts for 70% of all mammary carcinoma (MC) cases. ER+ MC patients display a prolonged clinical dormancy state, with a 70% recurrence 5-20 years after ...

Insulin-like growth factor binding protein 2 is a marker for antiestrogen resistant human breast cancer cell lines but is not a major growth regulator.

One hundred sixty-two (162) patients were enrolled. The inclusion criteria were as follows: 1) patients with histologically confirmed BC, 2) in adjuvant treatment with 20 mg of tamoxifen (Novadex®) ...

Introduction: Intracardiac leiomyomatosis is a rare, histologically benign, but biologically aggressive tumor developed from uterus. This study aimed to summarize our experience with one-stage surgery ...

International Research Center for Marine Biosciences at Shanghai Ocean University, Ministry of Science and Technology, Shanghai Ocean University, Shanghai 201306, China ...

1Department of Molecular and Systems Biology, Dartmouth Geisel School of Medicine, Lebanon, New Hampshire.